Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07633171 · ClinicalTrials.gov registry record
Multimodal Glucose Prediction in Type 2 Diabetes
A clinical trial, sponsored by Johns Hopkins University.
- Not yet
- Registry status
- 36
- Enrollment target
NCT07633171: Clinical Trial study, sponsored by Johns Hopkins University.
NCT07633171 is a clinical trial that has not yet begun recruiting, run by Johns Hopkins University. The registered enrollment target is 36 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07633171 has not yet begun recruiting, sponsored by Johns Hopkins University.
- NOT YET RECRUITING
- Registry status
- 36 participants
- Enrollment target
Study Summary
The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-time glucose prediction and personalized diabetes management for patients with Type 2 diabetes (T2D), delivered via mobile apps and digital health tools.
Interventions
- DEVICE Digital Health Data Collection System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-02-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07633171
The ClinicalTrials.gov registry entry for NCT07633171 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital Health Data Collection System is the first listed.
NCT07633171 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07633171 about?
NCT07633171 is a clinical study titled "Multimodal Glucose Prediction in Type 2 Diabetes". The primary objective of this research, funded by Samsung Strategic Alliance for Research and Technology, is to develop multi-modal foundation models that integrate Continuous Glucose Monitoring (CGM) data with patient behavior data (food intake, medication, and physical activity) to improve real-ti...
What is the current status of trial NCT07633171?
This trial is currently not yet recruiting. The enrollment target is 36 participants. The study started on 2026-06-15. Estimated completion is 2027-02-26.
What interventions are being tested in trial NCT07633171?
The interventions under investigation include: Digital Health Data Collection System (DEVICE).
Who is sponsoring clinical trial NCT07633171?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.